Skip to main content
logo
Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
14.76
-0.77 (-4.96%)
Mar 27, 2026, 4:00 PM EDT - Market closed

Nurix Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Dec - Nov.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Market Cap
1,5261,8001,6783035841,287
Market Cap Growth
52.48%7.30%453.58%-48.15%-54.60%-22.29%
Enterprise Value
989.061,2601,08838.25281.761,001
Last Close Price
14.7617.6822.116.2212.3928.82
PE Ratio
--5.80-7.68-2.35-3.34-10.56
PS Ratio
18.1721.4330.753.9415.1343.27
PB Ratio
2.793.343.181.511.923.76
P/TBV Ratio
2.382.842.821.691.983.61
P/FCF Ratio
--6.83-9.21-3.39-3.40-14.30
P/OCF Ratio
--7.22-9.70-3.74-3.66-15.26
EV/Sales Ratio
11.7815.0019.950.507.2933.64
EV/EBITDA Ratio
--4.72-5.54-0.27-1.63-8.95
EV/EBIT Ratio
--4.41-5.11-0.25-1.53-8.49
EV/FCF Ratio
--4.78-5.97-0.43-1.64-11.12
Debt / Equity Ratio
0.100.100.040.120.020.03
Debt / EBITDA Ratio
-0.21-0.21-0.14-0.22-0.07-0.12
Debt / FCF Ratio
-0.28-0.21-0.15-0.34-0.07-0.14
Net Debt / Equity Ratio
-1.00-1.00-1.10-1.28-0.98-0.83
Net Debt / EBITDA Ratio
2.002.012.961.821.722.53
Net Debt / FCF Ratio
2.682.043.192.881.733.14
Asset Turnover
0.120.120.110.200.090.07
Quick Ratio
6.866.866.363.314.384.56
Current Ratio
7.027.026.463.404.514.70
Return on Equity (ROE)
-49.63%-49.63%-53.22%-57.10%-55.84%-37.05%
Return on Assets (ROA)
-42.21%-42.21%-41.63%-40.15%-41.16%-27.03%
Return on Invested Capital (ROIC)
-1453.85%-1453.85%-915.50%-266.33%-153.24%-89.64%
Return on Capital Employed (ROCE)
-48.62%-48.62%-50.59%-50.45%-48.60%-30.93%
Earnings Yield
-17.33%-17.25%-13.03%-42.60%-29.94%-9.47%
FCF Yield
-17.26%-14.64%-10.86%-29.53%-29.44%-6.99%
Buyback Yield / Dilution
-29.12%-29.12%-23.52%-11.79%-13.32%-173.68%
Total Shareholder Return
-29.12%-29.12%-23.52%-11.79%-13.32%-173.68%
Updated Nov 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q